93 related articles for article (PubMed ID: 22588875)
21. Tumor endothelial marker 7 (TEM-7): a novel target for antiangiogenic therapy.
Bagley RG; Rouleau C; Weber W; Mehraein K; Smale R; Curiel M; Callahan M; Roy A; Boutin P; St Martin T; Nacht M; Teicher BA
Microvasc Res; 2011 Nov; 82(3):253-62. PubMed ID: 21958527
[TBL] [Abstract][Full Text] [Related]
22. Biomarkers of anti-angiogenic therapy in metastatic colorectal cancer (mCRC): original data and review of the literature.
Pohl M; Werner N; Munding J; Tannapfel A; Graeven U; Nickenig G; Schmiegel W; Reinacher-Schick A
Z Gastroenterol; 2011 Oct; 49(10):1398-406. PubMed ID: 21964893
[TBL] [Abstract][Full Text] [Related]
23. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?
Rafii S; Lyden D; Benezra R; Hattori K; Heissig B
Nat Rev Cancer; 2002 Nov; 2(11):826-35. PubMed ID: 12415253
[No Abstract] [Full Text] [Related]
24. Endothelial-like vascular progenitor cells (VPCs) from allogeneic and autologous donors: mobilization features distinct from hematopoietic progenitors.
Allan DS; Dubé P; Roy J; Busque L; Roy DC
Biol Blood Marrow Transplant; 2007 Apr; 13(4):433-9. PubMed ID: 17382249
[TBL] [Abstract][Full Text] [Related]
25. Influence of short-term rosuvastatin therapy on endothelial progenitor cells and endothelial function.
Pirro M; Schillaci G; Romagno PF; Mannarino MR; Bagaglia F; Razzi R; Pasqualini L; Vaudo G; Mannarino E
J Cardiovasc Pharmacol Ther; 2009 Mar; 14(1):14-21. PubMed ID: 19158317
[TBL] [Abstract][Full Text] [Related]
26. Antitumor effects of Endostar on non-Hodgkin's lymphoma by regulating endothelial progenitor cells through protein kinase B-dependent pathway.
Yu D; Wu H; Yang B; Yang K; Liu H; Wu G
Acta Biochim Biophys Sin (Shanghai); 2013 Sep; 45(9):742-8. PubMed ID: 23811754
[TBL] [Abstract][Full Text] [Related]
27. Effects of rapamycin and tacrolimus on mature endothelial cells and endothelial progenitor cells.
Macunluoglu B; Atakan A; Gökçe I; Ari E; Tulunay A; Demiralp E; Tuglular S; Ozener C
J Pak Med Assoc; 2012 Aug; 62(8):822-5. PubMed ID: 23862258
[TBL] [Abstract][Full Text] [Related]
28. Influence of ranibizumab on vascular endothelial growth factor plasma level and endothelial progenitor cell mobilization in age-related macular degeneration patients: safety of intravitreal treatment for vascular homeostasis.
Machalińska A; Paczkowska E; Pabin T; Safranow K; Karczewicz D; Machaliński B
J Ocul Pharmacol Ther; 2011 Oct; 27(5):471-5. PubMed ID: 21830945
[TBL] [Abstract][Full Text] [Related]
29. Mobilization of endothelial progenitor cells by intravenous cyclophosphamide in patients with systemic sclerosis.
Furuya Y; Okazaki Y; Kaji K; Sato S; Takehara K; Kuwana M
Rheumatology (Oxford); 2010 Dec; 49(12):2375-80. PubMed ID: 20724431
[TBL] [Abstract][Full Text] [Related]
30. [Circulating endothelial cells: biomarkers for monitoring activity of antiangiogenic therapy].
Farace F; Bidart JM
Bull Cancer; 2007 Jul; 94 Spec No():S254-9. PubMed ID: 17846012
[TBL] [Abstract][Full Text] [Related]
31. Taking down tumors: vascular disrupting agents entering clinical trials.
O'Hanlon LH
J Natl Cancer Inst; 2005 Sep; 97(17):1244-5. PubMed ID: 16145041
[No Abstract] [Full Text] [Related]
32. Outgrowing endothelial progenitor-derived cells display high sensitivity to angiogenesis modulators and delayed senescence.
Ha JM; Kim MR; Oh HK; Lee BH; Ahn HY; Shin JC; Baek SH; Joe YA
FEBS Lett; 2007 Jun; 581(14):2663-9. PubMed ID: 17517392
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of circulating VEGFR2+ bone marrow-derived progenitor cells in patients with advanced cancer.
Massard C; Borget I; Le Deley MC; Taylor M; Gomez-Roca C; Soria JC; Farace F
Eur J Cancer; 2012 Jun; 48(9):1354-62. PubMed ID: 22370181
[TBL] [Abstract][Full Text] [Related]
34. In silico design and biological evaluation of a dual specificity kinase inhibitor targeting cell cycle progression and angiogenesis.
Latham AM; Kankanala J; Fearnley GW; Gage MC; Kearney MT; Homer-Vanniasinkam S; Wheatcroft SB; Fishwick CW; Ponnambalam S
PLoS One; 2014; 9(11):e110997. PubMed ID: 25393739
[TBL] [Abstract][Full Text] [Related]
35. Pericyte-targeting prodrug overcomes tumor resistance to vascular disrupting agents.
Chen M; Lei X; Shi C; Huang M; Li X; Wu B; Li Z; Han W; Du B; Hu J; Nie Q; Mai W; Ma N; Xu N; Zhang X; Fan C; Hong A; Xia M; Luo L; Ma A; Li H; Yu Q; Chen H; Zhang D; Ye W
J Clin Invest; 2017 Oct; 127(10):3689-3701. PubMed ID: 28846068
[TBL] [Abstract][Full Text] [Related]
36. Effects of resveratrol on endothelial progenitor cells and their contributions to reendothelialization in intima-injured rats.
J G; Cq W; Hh F; Hy D; Xl X; Ym X; By W; Dj H
J Cardiovasc Pharmacol; 2006 May; 47(5):711-21. PubMed ID: 16775512
[TBL] [Abstract][Full Text] [Related]
37. Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme B.
Wroblewski M; Bauer R; Cubas Córdova M; Udonta F; Ben-Batalla I; Legler K; Hauser C; Egberts J; Janning M; Velthaus J; Schulze C; Pantel K; Bokemeyer C; Loges S
Nat Commun; 2017 Aug; 8(1):269. PubMed ID: 28814715
[TBL] [Abstract][Full Text] [Related]
38. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
Shojaei F; Ferrara N
Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
[TBL] [Abstract][Full Text] [Related]
39. Neuroblast survival depends on mature vascular network formation after mouse stroke: role of endothelial and smooth muscle progenitor cell co-administration.
Nih LR; Deroide N; Leré-Déan C; Lerouet D; Soustrat M; Levy BI; Silvestre JS; Merkulova-Rainon T; Pocard M; Margaill I; Kubis N
Eur J Neurosci; 2012 Apr; 35(8):1208-17. PubMed ID: 22512253
[TBL] [Abstract][Full Text] [Related]
40. Erythropoietin increases circulating endothelial progenitor cells and reduces the formation and progression of cerebral aneurysm in rats.
Xu Y; Tian Y; Wei HJ; Chen J; Dong JF; Zacharek A; Zhang JN
Neuroscience; 2011 May; 181():292-9. PubMed ID: 21376106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
